News
Yale BioHaven Entrepreneurship Seminars Present Marinus Pharmaceuticals: "Reformulating for Successful Drug Development"
The Yale BioHaven Entrepreneurship Seminars series continues its spring schedule on Wednesday, February 7, featuring Marinus Pharmaceuticals, Inc. (Marinus), a new specialty pharmaceutical company dedicated to the development and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders.